The federal government and state authorities have begun fresh moves to address funding shortfalls affecting the provision of nutrition supplements for ...

A 10-year program to improve primary care in rural areas was scrapped by the Trump administration for a new one that doesn’t pay clinics directly.

Q4 2025 net product revenues of $54.3 million; 2025 full-year net product revenues of $227.3 million, representing a 49% increase over 2024 full-year net product revenues ...

Modus Therapeutics Holding AB ("Modus Therapeutics") hereby publishes year-end report for 2025. The report is available on the company's website ( ...

Geron Corporation (NASDAQ:GERN) Q4 2025 Earnings Call Transcript February 25, 2026 Geron Corporation misses on earnings ...

ADMA Biologics, Inc. (Nasdaq: ADMA) (“ADMA” or the “Company”), a U.S. based, end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty biologics, ...

Chief Executive Officer — Harout Semerjian Chief Commercial Officer — Ahmed ElNawawi Executive Vice President, Research and Development and Chief Medical Officer — Joseph Eid Chief Financial Officer — ...

Announced positive 12-week results from the 20 mg dose cohort of the Phase 1b PIONEER trial of pociredir in sickle cell disease (SCD) ―― 20 mg ...

A privacy-first AI can diagnose a life-shortening hormone disorder—just from a photo of your hand.

Anomaly scan is a specialised ultrasound test that helps detect 11 different structural and genetic abnormalities in the ...

Discusses MissionEB Phase III Trial and CORDStrom as a Disease-Modifying Therapy for RDEB February 26, 2026 1:00 PM ...

Novo Nordisk today announced that the US Food and Drug Administration (FDA) has approved three new indications for once-weekly Sogroya (R) (somapacitan-beco) injection 5 mg, 10 mg, or 15 mg, a ...